Current evidence suggests that the mixed lineage kinase family member DLK/MUK/ZPK might play a significant role in the regulation of cell growth and differentiation, particularly during the process of tissue remodelling. To further explore this working model, we have investigated the regulation of host and recombinant DLK in NIH3T3 and COS-1 cells undergoing apoptosis. Using calphostin C, a potent and selective inhibitor of protein kinase C and a recognized apoptosis inducer for various cell types, we demonstrate, by immunoblot analysis, that DLK protein levels are rapidly and dramatically down regulated during the early phases of apoptosis. Down regulation in calphostin C treated cells was also accompanied by the appearance of SDS and mercaptoethanol resistant high molecular weight DLK immunoreactive oligomers. Experiments aimed at elucidating the mechanism(s) underlying DLK oligomerization revealed that the tissue transglutaminase (tTG) inhibitor monodansylcadaverine antagonized the effects of calphostin C almost completely, thereby suggesting the involvement of a tTGcatalyzed reaction as the root cause of DLK down-regulation and accumulation as high molecular weight species. In support of this notion, we also show that DLK can serve as a substrate for tTG-dependent cross-linking in vitro and that this covalent post-translational modification leads to the functional inactivation of DLK. Taken together, these observations suggest that transglutamination and oligomerization may constitute a relevant physiological mechanism for the regulation of DLK activity.
INTRODUCTION
A variety of extracellular "stress" stimuli responsible for the induction of growth arrest and apoptosis in multicellular organisms are transduced from the cell membrane to the nucleus via a phosphorylation cascade involving members of the c-Jun N-terminal kinase (JNK) 1 subgroup of mitogen-activated protein kinases (MAPKs) (1) (2) (3) . Once activated, these signaltransducing kinases transit from their primary sub-cellular location to the nucleus where they phosphorylate specific Ser-Pro and Thr-Pro motifs on transcription factors, which in turn regulate the expression of prescribed sets of downstream effector genes. Phosphorylation of transcription factors by members of the JNK family is an integrative and dynamic process which correlates capable of eliciting an up or down regulation of gene expression, depending on the transcription factor(s) targeted (1) (2) (3) . Like the extracellular signal regulated kinase (ERK) and p38 subfamilies of MAPKs, the activation of JNKs requires the phosphorylation of two conserved threonine and tyrosine residues in subdomain VIII of their catalytic domains -a process catalyzed by the dual specificity MAPK kinases (MKKs) MKK4 (4) and MKK7 (5, 6) .
The latter are themselves substrates for activation by upstream MAPK kinase kinases (MKKKs).
Examples of JNK MKKKs identified in mammalian cells include the MAPK/ERK kinase kinases
(MEKKs), TGF-β-activated kinase (TAK), tumor progression locus-2 (Tpl-2), apoptosis signal-regulating kinase 1 (ASK1), and the mixed lineage kinases (MLKs) (7) .
The MLK family of MKKKs is composed of five distinct members, designated MLK1, MLK2, MLK3, DLK (also known as MUK and ZPK), and LZK, which share several unique structural features. These include a "hybrid" catalytic domain bearing amino acid and structural motifs found in serine/threonine and tyrosine kinases and two leucine/isoleucine zipper motifs and a proline-rich carboxy-terminal domain surmized to be intimately involved in facilitating protein/protein interactions (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Other motifs important for protein binding have also been identified in the MLK family members. For example, MLK2 and MLK3 both contain a Src homology 3 (SH3) domain in their respective amino-terminal regions.
These domains bind the GTPase dynamin and the Ste20-related protein kinase HPK1, respectively (18, 19) . Both kinases also possess functional Cdc42/Rac interactive binding (CRIB) motifs that mediate association with Cdc42 and Rac1 in a GTP-dependent manner (20, 21) .
Examples of other proteins capable of interacting with the carboxy-terminal region of MLK2
have recently been identified using the yeast two-hybrid system and include the Ca 2+ -binding protein hippocalcin, 14-3-3ε protein, and several members of the kinesin family of microtubule motor proteins (20) . The biological significance of these associations, however, remain to be determined.
In spite of our increasing knowledge regarding the involvement of MLKs in the JNK signaling cascade, relatively little is known about their physiological roles in mammalian cells or about the mechanisms responsible for their regulation in response to various stimuli. In this regard, recent studies from our laboratory have provided evidence in support of a role for the MLK family member DLK in regulating cell proliferation and differentiation, particularly during the process of tissue remodelling. This working model was originally formulated following the observation that DLK expression is not ubiquitously distributed during mouse embryogenesis, but is highest and apparently restricted to tissues where terminal cell differentiation is ongoing or where cell proliferation has strongly declined (22) . Subsequent reports have further revealed a strong correlation between DLK expression and tissue regeneration (23, 24) . In more recent studies, transfection and overexpression of DLK was shown to induce dramatic growth inhibition in several cell types, including fibroblasts (25) and primary cultured human keratinocytes (26) .
Interestingly, in the latter case, the ectopic expression of DLK led to the induction of terminal differentiation (26) . Although DLK, like most other signaling molecules, might carry out different functions depending on cellular context and microenvironment, these data, when considered in sum, strongly support a role for this kinase during such pivotal biological processes as cell growth, cell differentiation and/or cell survival.
In the present report, we investigated this working notion further by studying the regulation of DLK activity during apoptosis. To this end, cultures of NIH 3T3 and DLKtransfected COS-1 cells were exposed to calphostin C, a potent and selective inhibitor of protein kinase C (PKC) (27) . Calphostin C exposure concurrently leads to activation of JNK (28) and induces apoptotic cell death in various cellular backgrounds (29, 30) . We demonstrate that calphostin C-mediated apoptosis is characterized, in both cellular backgrounds, by a rapid and dramatic down regulation of DLK during the early phases of cell death, that this event is paralleled by the accumulation of high molecular weight DLK polymers and that the formation of DLK oligomers is almost completely antagonized by monodansylcadaverine, a specific inhibitor of the Ca 2+ -dependent cross-linking enzyme tissue transglutaminase (tTG) (31, 32) . We also show that DLK oligomers can be generated in vitro in the presence of purified tTG and that transglutamination results in altered kinase activity.
Immunoelectron microscopy. NIH 3T3 cells were seeded in 35-mm culture dishes and allowed to reach 70 % confluency. Cells were rinsed twice with phosphate-buffered saline (PBS) and fixed in paraformaldehyde-lysine-periodate fixative (34) for 4 h at room temperature. The cells were then permeabilized with saponin and incubated, in sequence, with DLK antiserum (33) followed by goat anti-rabbit antibodies coupled to 1.4 nm NANOGOLD® particles (Nanoprobes, Inc., Yaphank , NY). The samples were further fixed in 1.3 % glutaraldehyde, subjected to silver enhancement (HQ Silver Enhancement Kit, Nanoprobes Inc.) and postfixed in 1% osmium tetroxide/1% potassium ferrocyanide. Cells were then embedded in situ with Poly/Bed® 812 epoxy resin (Polysciences, Inc., Warrington, PA). Sections were cut to 70 nm, post-stained with uranyl acetate and lead citrate, and examined with a Philips Model 201 electron microscope.
Cytochemical staining of apoptotic cells. Nuclear morphology and chromatin condensation in response to calphostin C treatment were monitored by staining with the DNA-intercalating dye acridine orange. Briefly, cells were fixed in methanol/acetone, washed with PBS, and stained with acridine orange (1 mg/ml) for 1 min. Following a post-stain rinse in PBS cells were mounted onto glass slides, viewed and photographed by epifluorescence microscopy.
Plasmids and transfection.
A BamHI fragment of the mouse DLK cDNA (amino acids 30-662) (35) was inserted in frame with a hexahistidine (His)-tag sequence in the bacterial expression vector pET-30b (Novagen Inc., Madison, WI). The complete coding region of rat JNK cDNA was amplified by polymerase chain reaction (PCR) using pMT2 p54β SAPK-HA (a gift of Dr. J. (Invitrogen Corp., Carlsbad, CA) expression plasmid carrying the entire coding region of mouse DLK cDNA has been described elsewhere (33) . A COOH-terminal truncated construct encoding amino acid residues 1 to 719 of DLK was generated by PCR using Pwo polymerase and subcloned into the mammalian expression vector pLXSN (CLONTECH Laboratories Inc., Palo Alto, CA ). The downstream primer was designed to introduce an artificial stop codon in the amplified cDNA fragment. A NH 2 -and COOH-terminal truncated DLK construct (amino acid 160-511) tagged with the FLAG epitope sequence (DYKDDDDK) was generated similarly by PCR and inserted into pcDNA3 (Invitrogen Corp.). The upstream and downstream primers used for this amplification were designed to introduce artificial start and stop codons.
In preparation for gene transfer experiments, COS-1 cells in the exponential phase of growth were seeded at 3 X 10 6 viable cells per 60-mm dish and allowed to recover for 24 h. 
RESULTS

Subcellular distribution of DLK in mouse NIH 3T3 fibroblasts.
Since recent studies have indicated that DLK is subject to cell type-dependent variations in its subcellular distribution (33, 36, 37) , we began by monitoring the expression and defining the localization of native (i.e. host) DLK in NIH 3T3 cells. In agreement with our previous report (33) , Western blot analysis of total proteins isolated from NIH 3T3 cells using an antiserum specific for DLK revealed the presence of a major immunoreactive band at approximately 150 kDa (Fig. 1A) . The DLK antiserum also detected two smaller and less prominent fragments with Mr of 85 and 57 kDa. (Fig. 1A) or DLK antiserum pre-incubated with the recombinant protein as competitor demonstrated no immunoreactivity at all (data not shown). In order to circumscribe the subcellular location of each of these immunoreactive species, we prepared membrane, nuclear, and cytosolic fractions from NIH 3T3 cells. As shown in Fig. 1B , the 150 and 85 kDa forms of DLK were detected exclusively in the membrane and nuclear fractions, respectively, whereas the 57 kDa immunoreactive band was recovered within the cytosolic and nuclear fractions. A survey of the subcellular distribution of DLK at the ultrastructural level by immunoelectron microscopy further revealed distinct labeling for DLK in both the nucleus and cytosol (Fig. 1, C and E) , as well as within the Golgi complex (Fig. 1D) where DLK has been previously shown to behave like a peripheral membrane protein facing the cytosol (33) .
Immunogold labeling of other membranous structures such as the endoplasmic reticulum was never observed (Fig. 1E) . Taken together, these data demonstrate that the 150 kDa full-length endogenous DLK protein appears to be located primarily within the membranes of the Golgi apparatus in NIH 3T3 cells whereas the derivative lower molecular weight species appear to reside in the nucleus and/or cytosol.
Calphostin C induces apoptosis in NIH 3T3 cells. Calphostin C is a potent and selective inhibitor of PKC. The compound abrogates enzyme activity by interfering with the binding of diacylglycerol and phorbol esters within the PKC regulatory domain (27) . Recent studies have also disclosed that calphostin C can trigger the activation of the stress-responsive kinase JNK (28) and induce apoptosis (i.e. programmed cell death) in a variety of cellular backgrounds, albeit by an as yet unknown mechanism (29, 30) . We therefore began this section of our study by monitoring for hallmark features of apoptosis in calphostin C-treated NIH 3T3 cells. Using an antibody specific for the activated (i.e. cleaved) form of caspase-3, one of the key effector molecules in apoptotic cell death (38), we detected a gradual increase in caspase-3 activation as early as 3 h following treatment with 250 nM calphostin C -a dose known to affect cell survival in several cell types (39,40) ( Fig. 2A; upper panel) . Concurrent immuno-blotting of the lysates with a antibody specifically targeted to phospho-JNK1 also revealed that calphostin C was able to stimulate the phosphorylation of JNK1 as early as 1 h after initiation of the treatment (Fig. 2A, middle panel). Under these treatment conditions the levels of JNK1 protein remained constant ( Fig. 2A, lower panel) . Calphostin C exposure, therefore, appears to be able to stimulate JNK1 phosphorylation and activate caspase 3 in NIH 3T3 cells. The induction of apoptosis was also confirmed by monitoring nuclear morphology using the DNA-intercalating dye acridine orange. As depicted in Fig. 2C and 2D , exposure to calphostin C led to chromatin condensation and to the fragmentation of nuclei into small spherical bodies typical of apoptotic cell death. Additional morphological changes characteristic of apoptosis, such as cytoplasmic shrinkage, membrane blebbing, and loss of adherence, were also observed following exposure to calphostin C (data not shown).
Exposure to calphostin C causes down regulation of the membrane-associated form of DLK.
Since DLK is known to act as an upstream regulator of the stress-responsive kinase JNK (16), we next wished to determine if DLK levels were subject to regulation in response to an apoptotic stimulus. For this purpose, whole cell extracts were prepared from NIH 3T3 cells exposed to calphostin C (250 nM for 30 min) and processed for immunoblot analysis with the DLK antiserum. In cells exposed to solvent (Me 2 SO) alone the antiserum recognized the expected 150, 85 and 57 kDa immunoreactive bands (Fig. 3A) . Calphostin C treatment, however, led to the disappearance of the 150 kDa membrane-associated form of DLK (Fig. 3A) without altering the levels of the 85 and 57 kDa immunoreactive forms. To confirm that the membraneassociated form of DLK was indeed down regulated in response to calphostin C, lysates subjected to immunoprecipitation with the DLK antiserum. The immunoprecipitates were run on SDSPAGEls and processed for immunoblotting with the same antiserum. Fig. 3B (left panel) shows that the 150 kDa membrane-associated form of DLK disappeared almost completely upon exposure to calphostin C, whereas the level of the 85 kDa form remained essentially unchanged.
The 57 kDa band could not be detected under these conditions. Furthermore, calphostin C-mediated down regulation of the 150 kDa form of DLK was also observed when the lysates were immunoprecipitated with a combination of antibodies raised against phosphoserine, phosphothreonine, and phosphotyrosine prior to immunoblotting with the DLK antiserum (Fig.   3B, right panel) , suggesting that the membrane-associated form of DLK, which appears to exist as a phosphoprotein in unchallenged cells, is specifically targeted for down-regulation upon initiation of apoptosis by calphostin C.
In order to better appreciate the kinetics of DLK down regulation, we set out to monitor the levels of immunoreactive DLK protein at selected time points during the early phase of apoptotic induction. In this instance, we noted a significant down regulation of the membraneassociated form of DLK as early as 5 min after treatment with 250 nM calphostin C ( Fig. 3C; upper panel) with a gradual progression towards minimal levels being attained by 30 min. No further reduction in DLK levels were registered beyond this time point (data not shown).
Immunoblots processed in parallel with antibodies targeting JNK and gamma actin ensured that this trend was not attributed to variations in the loading of protein samples ( Fig. 3C ; middle and lower panels).
In conjunction with these experiments, we also investigated the dose response of the phenomenon. Under this scheme calphostin C induced down-regulation of DLK in a dosedependent manner. A dose of 50 nM was apparently sufficient to significantly affect the level of DLK protein within the 30 min exposure period (Fig. 3D) . (Fig. 3E) .
Down regulation of DLK by calphostin C is independent of PKC activity, proteolytic degradation
and subcellular localization. A series of experiments with inhibitors of various specificities were next performed in an attempt to identify candidate mechanisms responsible for calphostin Cinduced DLK down-regulation in NIH 3T3 cells. Initially, we sought to determine whether the effects of calphostin C on DLK could be recreated by modulating of the catalytic activity of PKC.
NIH 3T3 cells were therefore incubated with two potent PKC inhibitors, bisindolylmaleimide I (10 µM) or staurosporine (500 nM). These compounds, unlike calphostin C, target the ATPbinding site (41) rather than the regulatory domain. As depicted in the immunoblots presented in Because calphostin C has recently been observed to promoted the disassembly of the Golgi apparatus (43) , the site where the membrane-associated form of DLK is primarily localized in NIH 3T3 cells (33) , we decided to test whether disruption of the Golgi complex with brefeldin A (BFA) alone could also promote DLK down-regulation. When NIH 3T3 cells were exposed to BFA at a dose known to compromise the integrity of the Golgi apparatus in these cells (33), no effect on the levels of DLK were observed ( Fig. 4D; lane 3) . By contrast, addition of calphostin C to BFA-treated cells induced the dramatic decrease in DLK protein levels ( Fig. 4D ; lanes 4 and 5) characteristic of exposure to this compound alone ( Fig. 4D; lanes 1 and 2) . These findings, therefore, led us to conclude that down-regulation of the membrane-associated form of DLK in response to calphostin C was also independent of its subcellular localization to the Golgi apparatus.
Calphostin C induces oligomerization of DLK in NIH 3T3 as well as in transfected COS-1 cells.
In order to extend these findings, we next examined whether down regulation of DLK could be reconstituted in COS-1 cells transfected with a functional DLK expression construct. COS-1 cells were therefore transfected and exposed, 48 h later, to 250 nM calphostin C for 30 min before being processed for immunoblotting with the DLK antiserum. Although not as dramatic as in NIH 3T3 cells, the response to calphostin C treatment did bring about a noticeable decrease in ectopic DLK protein levels. In addition, exposure to calphostin led to the appearance of immunoreactive products with molecular masses exceeding 250 kDa ( Fig. 5A; lanes 3 and 4) . (Fig. 5A;   lanes 5 to 8) . Thus, the ability of calphostin C to induce the formation of these protein complexes does not appear to be significantly affected by the absence of the NH 2 and COOH terminal domains of DLK, which contain putative docking sites for Src homology 3 (SH3)-domain bearing proteins (15) .
In view of these observations, we next attempted to determine whether calphostin C could also induce the formation of high molecular weight immunoreactive products with the endogenous DLK expressed by NIH 3T3 cells. In a manner resembling the results of the transfection experiments in COS-1 cells, at least part of the DLK immunoreactivity from calphostin C-treated NIH 3T3 cells was found to be associated with high molecular weight complexes (greater than 250 kDa in apparent mobility) that were readily detectable, albeit after prolonged exposure to x-ray film, just below the junction of the stacking and running gels (Fig.   5B) . In order to test whether the production of high molecular weight DLK complexes could occur in response to another pro-apoptotic stimulus, NIH 3T3 cells were exposed to increasing doses of UV irradiation before being subjected to immunoblot analysis with the DLK antiserum.
The results presented in Fig. 5C demonstrate that irradiation with 250 to 1000 J/m 2 UV light also resulted in the progressive accumulation of the high molecular weight forms of DLK.
DLK is a potential substrate for tissue transglutaminases (tTG) in calphostin C-treated cells.
To characterize the molecular mechanism(s) contributing to the formation of the high molecular weight DLK products in response to calphostin C treatment, we asked whether DLK could serve as a substrate for tTGs, a family of cross-linking enzymes induced during apoptosis (31, 32) . To verify this postulate, NIH 3T3 cells were pre-incubated with the tTG-specific inhibitor monodansylcadaverine (44) carrying the intact/functional catalytic and leucine zipper domains) with guinea pig tTG. As shown in Fig. 7B , the recombinant form of DLK, which migrates in the native state as a doublet of approximately 70 kDa on Coomassie blue stained gels, was converted to a series of increasingly transglutaminated forms, some of which migrated within size ranges corresponding roughly to dimers and multimers, following incubation in the presence of tTG.
Because tTG-catalyzed protein cross-linking has been shown to alter the activity of several enzymes (45, 46) , we were compelled to determine how transglutamination might affect DLK activity in vitro. To test this, recombinant DLK was immunoprecipitated and incubated either in the absence or the presence of tTG. The immunocomplexes were then subjected to immunoblotting with the DLK antiserum and to in vitro sequential protein kinase assays with GST-MKK7, His-JNK, and GST-c-Jun as substrates for the phosphorylation cascade reaction.
As expected (Fig. 7C) , addition of tTG to immunoprecipitated recombinant DLK promoted the appearance of immunoreactive bands with molecular sizes consistent with the formation of DLK dimers and multimers. However, the generation of these transglutaminated species was paralleled by a significant decrease in the catalytic activity of the oligomers when compared to unmodified DLK (Fig. 7C) . The results of this exercise demonstrate that DLK catalytic activity can be significantly reduced following transglutamination and subsequent oligomerization.
DISCUSSION
Although advances over the past few years have contributed to our general understanding of how the mixed lineage kinase DLK regulates JNK signalling, little is currently known about the mechanisms affecting its own regulation, about the proteins it is most likely to interact with within the cell and about its physiological function(s). However, the documented involvement of JNK-dependent signalling events during cell growth and apoptosis infer equally important, or at the very least, supportive roles for involvement of DLK in the regulation of these cellular processes. In order to verify this working hypothesis, we chose to investigate candidate mechanisms for the regulation of DLK activity in cultured cells induced to undergo apoptosis following exposure to calphostin C. We provide evidence that calphostin C induces a rapid and dramatic decrease in the levels of the 150 kDa membrane/Golgi-associated from of DLK in NIH 3T3, Neuro-2a, and AtT-20 cells as well as in COS-1 cells transiently transfected with a functional DLK expression vector. We also demonstrate that the ability of calphostin C to down regulate DLK expression is encountered during the early phases of the apoptotic response, namely, during that time period which precedes activation of JNK phosphorylation and caspase-phases of apoptosis.
Like all transglutaminases, tTG is a Ca 2+ -dependent cross-linking enzyme that catalyzes the post-translational modification of proteins by transamidation of specific polypeptide-bound glutamines (31, 32) . This activity commonly results in the formation of γ-glutamyl-ε-lysine isopeptide bonds within or between polypeptides chains that are of great physiological interest because of their exceptional stability and resistance to mechanical breakage and chemical attack.
Although the precise biological functions of tTGs are not fully understood, recent reports from several laboratories have suggested a participative role for protein polymers formed via tTGcatalyzed cross-links during apoptosis (31, 32) . In fact, it has been shown that expression and activity of tTG are both substantially increased at the onset of apoptosis in numerous cell types (47) (48) (49) (50) . Under these circumstances, the activation of tTG in dying cells leads to the formation of specific cross-linked protein polymers that are thought to be involved in some as yet unspecified way during the early and late stages of the apoptotic process (31, 32) . While some of the tTG substrates might presumably be involved in committing cells to apoptosis, others have been found to participate in the assembly of a detergent-insoluble cross-linked protein scaffold that prevents the leakage of macromolecules and inflammatory substances in the surrounding tissues (31, 32) . Thus, the up-regulation of tTG activity observed in vitro and in vivo in apoptotic cells might conceivably constitute one of the key elements characterizing or contributing to this particular type of cell death. To our knowledge, the results presented here add, for the first time, a cell survival regulatory protein kinase to the list of known cellular proteins that serve as substrates for tTG in dying cells. Examples of cross-linked protein polymers formed by tTG in cells undergoing programmed cell death include actin, annexin, troponin, involucrin, fibronectin, histone H2B, and the retinoblastoma protein (32, 50) . In contrast to most of these intracellular proteins, which have also been found to be substrates of the thiol protease caspases and calpains in dying cells (31, 32) , our data indicate that tTG is the major effector element of the apoptotic response acting on the processing of DLK following exposure to calphostin C.
The finding that DLK undergoes tTG-dependent polymerization shortly after exposure to Although the molecular details surrounding DLK oligomerization and catalytic inactivation by tTG remain to be fully defined, it is not unreasonable to suspect that select glutamine and lysine residues located within or in close structural proximity to the catalytic and/or regulatory domains may serve as potential acceptor sites for transglutamination by tTG.
The kinase domain of DLK actually contains 7 glutamine and 14 lysine residues which may act as acyl donors and acceptor substrates, respectively, for tTG-catalyzed reactions.
In summary, this report provides strong in vivo and in vitro evidence that the mixed 
